^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Rhabdomyosarcoma |
| Drug: | dactinomycin (Topoisomerase II inhibitor, RNA synthesis inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
COSMEGEN is indicated for the treatment of:...adult and pediatric patients with rhabdomyosarcoma, as part of a multiphase, combination chemotherapy regimen.
